(Q34774061)

4 August 2017

title

Quadruple rescue therapy for Helicobacter pylori infection after two treatment failures (English)

1 reference

Helicobacter pylori infectious disease

4 August 2017

0 references

1 reference

P I Hsu

1

1 reference

4 August 2017

D C Wu

2

1 reference

4 August 2017

A Chen

3

1 reference

4 August 2017

N J Peng

4

1 reference

4 August 2017

H H Tseng

5

1 reference

4 August 2017

F W Tsay

6

1 reference

4 August 2017

G H Lo

7

1 reference

4 August 2017

C Y Lu

8

1 reference

4 August 2017

F J Yu

9

1 reference

4 August 2017

K H Lai

10

1 reference

4 August 2017

publication date

22 April 2008

1 reference

European Journal of Clinical Investigation

4 August 2017

published in

1 reference

4 August 2017

volume

38

1 reference

4 August 2017

issue

6

1 reference

4 August 2017

page(s)

404-409

1 reference

A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Pantoprazole based therapies in Helicobacter pylori eradication: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Lansoprazole, levofloxacin and amoxicillin triple therapy vs. quadruple therapy as second-line treatment of resistant Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Review article: Helicobacter pylori "rescue" regimen when proton pump inhibitor-based triple therapies fail.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Eradication of Helicobacter pylori: recent advances in treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Randomized controlled study of rabeprazole, levofloxacin and rifabutin triple therapy vs. quadruple therapy as second-line treatment for Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Impact of furazolidone-based quadruple therapy for eradication of Helicobacter pylori after previous treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Review article: the treatment of refractory Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

A triple therapy regimen after failed Helicobacter pylori treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Optimal dose of omeprazole for CYP2C19 extensive metabolizers in anti-Helicobacter pylori therapy: pharmacokinetic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

The effect of CYP2C19 polymorphisms on H. pylori eradication rate in dual and triple first-line PPI therapies: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

CYP2C19 polymorphism is a major predictor of treatment failure in white patients by use of lansoprazole-based quadruple therapy for eradication of Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Eradication of Helicobacter pylori prevents ulcer development in patients with ulcer-like functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Polymerase chain reaction: a sensitive method for detecting Helicobacter pylori infection in bleeding peptic ulcers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Endoscopic 13C-urea breath test for the diagnosis of Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Clinical significance of oral urease in diagnosis of Helicobacter pylori infection by [13C]urea breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Clinical presentation in relation to diversity within the Helicobacter pylori cag pathogenicity island.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

A 10-day levofloxacin-based triple therapy in patients who have failed two eradication courses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Third-line rescue therapy with levofloxacin after two H. pylori treatment failures

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Pharmacogenomics of proton pump inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

Multilaboratory Comparison of Proficiencies in Susceptibility Testing of Helicobacter pylori and Correlation between Agar Dilution and E Test Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2362.2008.01951.X

10.1111/J.1365-2362.2008.01951.X

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference